KRITI NUTRIENTS Latest Share Price (KRITINUT)
TODAY IN ONE LINE
KRITINUT jumped 4.8% on above-average volume (833421.1x avg), outperforming Nifty's 1.0% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹365 Cr., it trades at a P/E of 10.67. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
KRITI NUTRIENTS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Price MomentumRobust returns of 56.3% over 1Y
- ●Consistent GrowthEPS compounded at 44.3% over 3 years
- ●High Capital EfficiencyROCE of 18.0% indicating pricing power
- ●Reasonable ValuationTrading at a moderate P/E of 12.3x
- ●High Promoter HoldingPromoters hold 66.7% skin-in-the-game
- ●Steady Dividend YieldReliable 4.31% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.03x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 32.7% YoY
Latest KRITI NUTRIENTS News
What changed recently?
Recent events, corporate actions, and announcements.
KRITI NUTRIENTS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for KRITI NUTRIENTS, framed against the sector median so the premium or discount is obvious at a glance.
KRITI NUTRIENTS trades at a P/E of 10.67× and P/B of 1.55×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
KRITI NUTRIENTS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for KRITI NUTRIENTS — derived from the latest tape, not yesterday's close.
KRITI NUTRIENTS last traded at ₹72.61 with an intraday range of ₹70.11–₹72.72 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹72.61| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 78.74 | +6.13 | +8.44% |
| R3 | 76.13 | +3.52 | +4.84% |
| R2 | 74.42 | +1.81 | +2.50% |
| R1 | 73.52 | +0.91 | +1.25% |
| PIVOT | 71.81 | -0.80 | -1.10% |
| CURRENT | 72.61 | — | — |
| S1 | 70.91 | -1.70 | -2.35% |
| S2 | 69.20 | -3.41 | -4.69% |
| S3 | 68.30 | -4.31 | -5.94% |
| S4 | 65.69 | -6.92 | -9.53% |
KRITINUT is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹70.11–₹72
Trading Above opening range, showing Bullishness
KRITI NUTRIENTS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for KRITI NUTRIENTS — consolidated or standalone — with margins, YoY growth and key ratios inline.
KRITI NUTRIENTS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹365 Cr. and reported EPS of ₹1.78.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 734 | 922 ▲ 25.5% |
| Sales Growth YoY %Derived | — | 25.49% |
| Other Income | 8 | 8 ▲ 2.6% |
| Total Income | 742 | 929 ▲ 25.3% |
| 632 | 821 ▲ 30.0% | |
| Gross ProfitDerived | 103 | 100 ▼ 2.4% |
| Gross Margin %Derived | 13.99% | 10.88% |
| 55 | 57 ▲ 3.9% | |
| EBITDA (Operating Profit)Derived | 48 | 43 ▼ 9.5% |
| OPM %Derived | 6.54% | 4.71% |
| 6 | 6 ▲ 4.7% | |
| Profit Before Tax (PBT) | 50 | 45 ▼ 9.4% |
| 13 | 11 ▼ 11.6% | |
| Effective Tax %Derived | 25.62% | 24.98% |
| Total Profit for Period | 37 | 34 ▼ 8.4% |
| Net Profit (Owner's PAT)Derived | 37 | 34 ▼ 8.4% |
| Net Profit Margin %Derived | 5.04% | 3.68% |
| PAT Growth YoY %Derived | — | -8.36% |
| Earnings Per Share (EPS ₹) | 7.38 | 6.77 ▼ 8.3% |
| Diluted Shares Outstanding (Cr) | 5 | 5 ▲ 0.0% |
| Share of Profit from Associates/JVs | -0 | 0 ▲ 300.7% |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 14.2% |
| Total Expenses (incl. D&A & Interest) | 692 | 884 ▲ 27.7% |
| Material Cost % of RevenueDerived | 81.69% | 83.58% |
| Employee Cost % of RevenueDerived | 2.79% | 2.14% |
| Other Cost % of RevenueDerived | 4.66% | 4.03% |
| Interest Coverage (x)Derived | 74.35x | 68.81x |
| Period | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|
| Revenue from Operations | 734 | 922 ▲ 25.5% | |
| Sales Growth YoY %Derived | — | 25.49% | |
| Other Income | 8 | 8 ▲ 2.6% | |
| Total Income | 742 | 929 ▲ 25.3% | |
632 | 821 ▲ 30.0% | ||
| Gross ProfitDerived | 103 | 100 ▼ 2.4% | |
| Gross Margin %Derived | 13.99% | 10.88% | |
55 | 57 ▲ 3.9% | ||
| EBITDA (Operating Profit)Derived | 48 | 43 ▼ 9.5% | |
| OPM %Derived | 6.54% | 4.71% | |
6 | 6 ▲ 4.7% | ||
| Profit Before Tax (PBT) | 50 | 45 ▼ 9.4% | |
13 | 11 ▼ 11.6% | ||
| Effective Tax %Derived | 25.62% | 24.98% | |
| Total Profit for Period | 37 | 34 ▼ 8.4% | |
| Net Profit (Owner's PAT)Derived | 37 | 34 ▼ 8.4% | |
| Net Profit Margin %Derived | 5.04% | 3.68% | |
| PAT Growth YoY %Derived | — | -8.36% | |
| Earnings Per Share (EPS ₹) | 7.38 | 6.77 ▼ 8.3% | |
| Diluted Shares Outstanding (Cr) | 5 | 5 ▲ 0.0% | |
| Share of Profit from Associates/JVs | -0 | 0 ▲ 300.7% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 14.2% | |
| Total Expenses (incl. D&A & Interest) | 692 | 884 ▲ 27.7% | |
| Material Cost % of RevenueDerived | 81.69% | 83.58% | |
| Employee Cost % of RevenueDerived | 2.79% | 2.14% | |
| Other Cost % of RevenueDerived | 4.66% | 4.03% | |
| Interest Coverage (x)Derived | 74.35x | 68.81x |
KRITI NUTRIENTS segment analysis : revenue and profit mix.
Disclosed business segments at KRITI NUTRIENTS with their share of revenue and profit, switchable between consolidated and standalone reporting.
KRITI NUTRIENTS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for KRITI NUTRIENTS.
Our AI distills the core fundamental drivers supporting KRITI NUTRIENTS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
KRITI NUTRIENTS's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 14 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 10% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 2.15%.
KRITI NUTRIENTS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — KRITI NUTRIENTS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
KRITI NUTRIENTS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for KRITI NUTRIENTS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
KRITI NUTRIENTS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for KRITI NUTRIENTS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in KRITI NUTRIENTS stood at 82.5% of traded volume, against a 20-day average of 76.7%.
KRITI NUTRIENTS announcements: results, concalls, ratings, M&A.
Filings KRITI NUTRIENTS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
KRITI NUTRIENTS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 62 documents below.
Trading Window
Kriti Nutrients Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,…
Reply to Clarification- Financial results
The Exchange had sought clarification from Kriti Nutrients Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI…
Shareholders meeting
Kriti Nutrients Limited has informed the Exchange with copy of minutes of Annual General Meeting held on August 12, 2026
Clarification - Financial Results
The Exchange has sought clarification from Kriti Nutrients Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI…
Change in Management
Kriti Nutrients Limited has informed the Exchange about change in Management - Intimation under Regulation 30(2) of Securities and Exchange Board of…
KRITI NUTRIENTS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue KRITI NUTRIENTS has declared, sequenced by announce and record date.
KRITI NUTRIENTS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About KRITI NUTRIENTS: business, sector, key facts.
What KRITI NUTRIENTS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
KRITI NUTRIENTS operates in the Edible Oil industry under the Fast Moving Consumer Goods sector, listed as NSE: KRITINUT, BSE: 533210.
Kriti Nutrients Limited is an Indian company established in 1992, headquartered in Indore. Its core business revolves around the production and sale of soybean-based products, primarily under the "Kriti" brand name. This includes a wide range of offerings catering to both domestic and international markets.
A significant portion of Kriti Nutrients' business focuses on the soybean seed market. They cultivate and sell soybean seeds, a foundational element for many of their downstream products and a key component in the agricultural sector. This underscores their commitment to the entire soybean value chain, from seed production to final consumer products.
Beyond soybean seeds, the company produces and distributes a diverse range of edible oils. This includes refined sunflower oil, soybean oil, filtered groundnut oil, and mustard oil, targeting various consumer preferences and culinary traditions. The production of these oils represents a significant part of their revenue streams and showcases their involvement in the broader edible oil market.
Kriti Nutrients also offers a substantial line of soy-based derivatives, showcasing their vertically integrated business model. These include soya lecithin, a versatile emulsifier used in food processing and other industries. They also produce various forms of soy protein, such as protein-based nuggets (TVP), full-fat soya flour, and defatted soy flakes and flours (both toasted and untoasted). Further, they provide Super HyPro SBM (Soybean Meal) and soya hulls, highlighting their dedication to utilizing the entire soybean plant for different applications.
The company's products serve a wide spectrum of industries. Their offerings are used in food processing, pharmaceuticals, aquaculture, poultry farming, infant nutrition, and the dairy industry. This diversification into multiple sectors minimizes dependence on any single market and demonstrates a strategic approach to expanding their customer base and market reach. Kriti Nutrients Limited is a subsidiary of Sakam Trading Private Limited, reflecting its position within a larger corporate structure.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AWL AGRI BUSINESS (AWL) Share PricePeer
- GOKUL REFOILS & SOLV (GOKUL) Share PricePeer
- GOKUL AGRO RESOURCES (GOKULAGRO) Share PricePeer
- MARICO (MARICO) Share PricePeer
- M K PROTEINS (MKPL) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about KRITI NUTRIENTS (KRITINUT).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of KRITI NUTRIENTS (KRITINUT)?
The current share price of KRITI NUTRIENTS (KRITINUT) is ₹72.61. Today, the stock has gained by ₹3.35 (4.84%), trading in a range of ₹70.11 to ₹72.72. The stock opened at ₹70.11 with a trading volume of 9,501 shares.
02Is KRITI NUTRIENTS stock a good investment for long-term?
KRITI NUTRIENTS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹365 Cr., P/E ratio of 10.67, ROE of 14.8%, and ROCE of 17.99%. The dividend yield stands at 4.31%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of KRITI NUTRIENTS stock?
The 52-week high price of KRITI NUTRIENTS (KRITINUT) is ₹102.99, while the 52-week low is ₹51.36. Currently trading at ₹72.61, the stock is 41.37% above its 52-week low and 29.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy KRITI NUTRIENTS stock at the current price?
Whether to buy KRITI NUTRIENTS stock at ₹72.61 depends on multiple factors. The stock is currently trading with a P/E ratio of 10.67 and P/B ratio of 1.55. Today's performance shows a gain of 4.84%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of KRITI NUTRIENTS and when is the next dividend?
KRITI NUTRIENTS offers a dividend yield of 4.31%, which means for every ₹100 invested at the current price of ₹72.61, you can expect to receive approximately ₹4.31 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of KRITI NUTRIENTS?
KRITI NUTRIENTS's key financial metrics include: P/E Ratio: 10.67, P/B Ratio: 1.55, ROE: 14.8%, ROCE: 17.99%, Dividend Yield: 4.31%, EPS: ₹1.78, Book Value: ₹45.73, and Debt-to-Equity: 0.03. The company's market cap stands at ₹365 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is KRITI NUTRIENTS stock performing today in the market?
KRITI NUTRIENTS stock opened at ₹70.11 and is currently trading at ₹72.61, showing a gain of ₹3.35 (4.84%). The intraday high is ₹72.72 and low is ₹70.11. The trading volume stands at 9,501 shares, indicating moderate market participation today.
08What is the P/E ratio of KRITI NUTRIENTS and what does it indicate?
KRITI NUTRIENTS has a Price-to-Earnings (P/E) ratio of 10.67, which means investors are willing to pay 10.67 for every ₹1 of earnings. With an EPS of ₹1.78, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about KRITI NUTRIENTS (KRITINUT) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.